Chronic Lung Disease of Prematurity Recruiting Phase 4 Trials for Budesonide (DB01222)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03521063Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.Prevention